Acurx Pharmaceuticals Inc (NASDAQ: ACXP) Has Succeeded In Gaining Momentum In 2025, The Stock Is Up 8.48% YTD
Acurx Pharmaceuticals Inc (NASDAQ:ACXP)’s traded shares stood at 0.68 million during the last session, with the company’s beta value hitting -1.71. At the close of